Edith Cowan University

Research Online
Research outputs 2014 to 2021
1-31-2019

Global access to antibiotics without prescription in community
pharmacies: A systematic review and meta-analysis
Asa Auta
Muhammad A. Hadi
Enoche Oga
Emmanuel O. Adewuyi
Edith Cowan University

Samirah N. Abdu-Aguye

See next page for additional authors

Follow this and additional works at: https://ro.ecu.edu.au/ecuworkspost2013
Part of the Public Health Commons
10.1016/j.jinf.2018.07.001
Auta, A., Hadi, M. A., Oga, E., Adewuyi, E. O., Abdu-Aguye, S. N., Adeloye, D., ... Morgan, D. J. (2019). Global access to
antibiotics without prescription in community pharmacies: A systematic review and meta-analysis. Journal of
Infection, 78(1), 8-18. https://doi.org/10.1016/j.jinf.2018.07.001
This Journal Article is posted at Research Online.
https://ro.ecu.edu.au/ecuworkspost2013/10825

Authors
Asa Auta, Muhammad A. Hadi, Enoche Oga, Emmanuel O. Adewuyi, Samirah N. Abdu-Aguye, Davies
Adeloye, Barry Strickland-Hodge, and Daniel J. Morgan

This journal article is available at Research Online: https://ro.ecu.edu.au/ecuworkspost2013/10825

© 2019. This manuscript version is made available under the CC-BY-NC-ND
4.0 license http://creativecommons.org/licenses/by-nc-nd/4.0/

Global access to antibiotics without prescription in community pharmacies: a
systematic review and meta-analysis

Asa Auta1*, Muhammad Abdul Hadi2, Enoche Oga1, Emmanuel O. Adewuyi3, Samirah N.
Abdu-Aguye4, Davies Adeloye5, Barry Strickland-Hodge6, Daniel J. Morgan7,8

School of Pharmacy and Biomedical Sciences, University of Central Lancashire, Preston,

1

PR1 2HE, United Kingdom
Leicester School of Pharmacy, De Montfort University, Hawthorn Building, Leicester LE1

2

9BH, United Kingdom
Statistical and Genomic Epidemiology Laboratory, Institute of Health and Biomedical

3

Innovation, Queensland University of Technology, Brisbane, Australia.
Department of Clinical Pharmacy and Pharmacy Practice, Faculty of Pharmaceutical

4

Sciences, Ahmadu Bello University, Zaria, Nigeria
Centre for Global Health Research and the World Health Organization Collaborating Centre

5

for Population Health Research and Training, Usher Institute, University of Edinburgh, UK.
School of Healthcare, Faculty of Medicine and Health, University of Leeds, Leeds, LS2 9JT,

6

UK.
Department of Epidemiology and Public Health, University of Maryland School of Medicine

7

and the VA Maryland Healthcare System, Baltimore, MD, USA
Centers for Disease Dynamics, Economics and Policy (CDDEP), Washington DC, USA.

8

*Corresponding author: Asa Auta, School of Pharmacy and Biomedical Sciences, University
of Central Lancashire, Preston, PR1 2HE, UK. Email: aauta@uclan.ac.uk

1

Abstract
Objective: To estimate the proportion of over-the-counter antibiotic requests or consultations
that resulted in non-prescription supply of antibiotics in community pharmacies globally.
Methods: We systematically searched EMBASE, Medline and CINAHL databases for studies
published from January 2000 to September 2017 reporting the frequency of non-prescription
sale and supply of antibiotics in community pharmacies across the world. Additional articles
were identified by checking reference lists and a Google Scholar search. A random effects
meta-analysis was conducted to calculate pooled estimates of non-prescription supply of
antibiotics.
Results: Of the 3302 articles identified, 38 studies from 24 countries met the inclusion criteria
and were included in the review. All the included countries with the exception of one, classified
antibiotics as prescription-only medicines. The overall pooled proportion of non-prescription
supply of antibiotics was 62% (95% CI 53 – 72). The pooled proportion of non-prescription
supply of antibiotics following a patient request was 78% (95% CI 59 - 97) and based on
community pharmacy staff recommendation was 58% (95% CI 48 – 68). The regional supply
of non-prescription antibiotics was highest in South America, 78% (95% CI 72 - 84). Antibiotics
were commonly supplied without a prescription to patients with symptoms of urinary tract
infections (68%, 95% CI 42 – 93) and upper respiratory tract infections (67%, 95% CI 55 - 79).
Fluoroquinolones and Penicillins respectively were the most commonly supplied antibiotic
classes for these indications.
Conclusion: Antibiotics are frequently supplied without prescription in many countries. This
overuse of antibiotics could facilitate the development and spread of antibiotic resistance.

Keywords: antibiotics; non-prescription supply; community pharmacies; infections; antibiotic
stewardship.
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Introduction
Antibiotics are the most frequently prescribed medicines world-wide.1 Between 2000 and
2010, consumption of antibiotics increased from approximately 50 billion to 70 billion standard
units.1 More than three-quarters of the overall increase in consumption of antibiotics occurred
in Brazil, Russia, India, China, and South Africa.1 This global increase in consumption has
been driven by a number of factors including economic growth and access to antibiotics.1
However, the growing access to and use of antibiotics (either through prescription or nonprescription) has been linked to antibiotic resistance, which is a significant threat to global
public health.1-3 Antibiotic resistance accounts for more than 2 million infections and at least
23,000 deaths annually in the USA 4 and about 25,000 deaths in Europe 5. Although reliable
estimates of the burden of antibiotic-resistant infections in developing countries are lacking, it
is believed to cause many more deaths in these countries. For example, in India alone, about
57,000 neonatal sepsis deaths occurring annually are due to antibiotic-resistant infections.5
About 80% of antibiotics are used in the community.6 These antibiotics are either prescribed
by a healthcare professional or purchased directly by consumers without a valid prescription
from many sources including community pharmacies. In many countries, the dispensing of
antibiotics without a prescription is illegal. Nevertheless, over 50% of antibiotics worldwide are
obtained without a prescription and community pharmacies are a major source of nonprescribed antibiotics.7 This practice is particularly common in developing countries where
there are no regulations regarding the sale and distribution of medicines or the enforcement
of these regulations is weak.8, 9 Recent evidence has indicated that dispensing antibiotics
without a prescription is becoming a problem in developed countries including Portugal and
Spain.10, 11
Non-prescription use of antibiotics is often associated with incomplete/shorter treatment
courses and inappropriate drug and dose choices.12-14 Such irrational use of antibiotics could
have a number of consequences including the development and spread of resistance to
antibiotics, delayed hospital admissions and masking the diagnosis of infectious diseases.1215

For example, tuberculosis symptoms suppressed temporarily through the use of

fluoroquinolones could delay its diagnosis and lead to the patients receiving several antibiotic
courses for the wrong diagnosis.15 While in recent times, several interventions designed to
optimise the use of antibiotics have been developed, they are often targeted at hospitals
thereby missing the non-prescription sources of antibiotics.16
To address the problem of non-prescription use of antibiotics, an understanding of the
magnitude of the practice and circumstances in which it occurs is important in the first
instance. Previous reviews have focussed on the frequency of non-prescribed use of
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antibiotics in the general population and have identified community pharmacies as important
sources of these antibiotics.16, 17 However, the review by Morgan et al.,16 provided additional
analysis on the frequency of community pharmacists’ recommendation of non-prescribed
antibiotics. The analysis by Morgan et al.,16 was limited to 13 studies and without specific
estimates by country, region or symptom. Hence, a more robust and updated analysis is
needed. Therefore, we estimated the frequency of the supply of antibiotics without a
prescription in community pharmacies globally identifying regions where this practice
commonly occurs, the disease conditions commonly treated with non-prescribed antibiotics
and the types of antibiotics commonly supplied without a prescription in community
pharmacies.
Methods
Search strategy
We searched EMBASE, Medline and CINAHL to identify studies published from January 2000
to September 2017 that reported the sale and dispensing of non-prescribed antibiotics in
community pharmacies. Search terms used including antibiotics, community pharmacy, sales
and dispensing were combined using Boolean operators (See Box1). Additional articles were
identified by checking reference lists and Google scholar search. No language or geographical
restrictions were applied to the search. The research protocol was registered in the
PROSPERO international prospective register of systematic reviews (CRD42017058156).
Eligibility criteria for included studies
Two reviewers, AA and DA independently screened studies against the inclusion and
exclusion criteria with a Kappa agreement of 91.9%. Discrepancies were resolved through
consensus. We included observational and experimental studies that reported the proportion
of over-the-counter antibiotic requests or consultations in relation to symptoms of suspected
infectious diseases that resulted in non-prescription supply of antibiotics in community
pharmacies. Population-based surveys that explored pharmacists’ and public opinions on the
supply and/or sources of non-prescription antibiotics were excluded. We also excluded
qualitative studies (with no quantitative measures of non-prescription supply of antibiotics),
reviews, editorials and conference reports.
Assessment of risk of bias of included studies
All studies were assessed for quality and risk of bias on eight criteria modelled largely from
the ‘Strengthening the Reporting of Observational Studies in Epidemiology framework’.18
These criteria were: detailed description of research setting, sample size, sampling strategy,
clear definition of clinical/product-request scenario, reliability of measurement, social
4

desirability, statistical analysis methods and generalisability of results. Each risk of bias criteria
was assessed as low (scored as 1), moderate/high or unclear (scored as 0). The total score
for each study was computed.

All studies were classified into one of the three levels of bias

depending on their total scores, 0-2 (high risk), 3-5 (moderate risk) and 6-8 (low risk).
Data extraction
Data were extracted by two reviewers (AA & DA) and any discrepancy was resolved by
consensus. The following data were extracted; author, year of publication, study country,
sample size, number of visits/interactions observed, proportion of non-prescribed sale and
supply of antibiotics. Other data extracted include types of symptoms/disease conditions
treated, types of antibiotics dispensed and nature of information given during consultation.
Data analysis
Statistical analyses were performed using Stata version 13.1 (StataCorp. LP, College Station,
USA). A random effects meta-analysis based on the DerSimonian and Laird approach,19 was
conducted to calculate pooled proportions (with 95% confidence interval) of the supply of
non-prescribed antibiotics for all included studies. The proportion of non-prescription supply
of antibiotics in this study was calculated as the percentage of over-the-counter antibiotic
requests or consultations in relation to symptoms of infectious diseases that resulted in the
supply of antibiotics without a prescription. Proportion data were also pooled by symptoms of
disease conditions, study period and types of antibiotics dispensed. I-squared (I2) statistics
were determined to assess the degree of heterogeneity across studies. Sub-group and metaregression analyses were conducted to explore the causes of heterogeneity. The co-variates
considered included geographical region, study period, sampling procedure (random vs
convenience sampling), number of community pharmacies, type of simulated scenario,
category of pharmacy staff, concealment in methodology and each risk of bias criteria. Covariates were first tested individually and only those with p-values below 0.01 were included
in the multivariate model. We performed sensitivity analysis to examine the effect of outliers
and test the robustness of our findings.
Results
Study selection and characteristics
We identified 3302 articles through the literature search, of which 38 met the inclusion criteria
(see figure 1). The 38 studies were conducted in 24 countries and involved 8085 interactions
within 6353 community pharmacies. Antibiotics are classified as prescription-only medicines
in all the countries included in this review with the exception of Thailand. In Thailand,
pharmacists are legally allowed to supply some antibiotics without a prescription.
5

The majority of the studies (23 out of 38) included in this review were conducted in Asia.
Almost all (37 out of 38) of the included studies were of cross-sectional design (Table 1). All
included studies used simulated patient methodology with 35 of the 38 studies involving
simulated-patient with concealed identities. The remaining three studies were based on
pharmacy staff interviews using simulated scenarios. A range of scenarios were simulated in
the included studies with the most common involving symptoms of upper respiratory tract
infections (URTI), gastroenteritis and urinary tract infections (UTI) in women of childbearing
age (Table 1).
The risk of bias assessment found that 15 (39%) studies had a low risk of bias while the
remaining 23 (61%) studies had a moderate risk. The most common source of bias among
the included studies was due to sampling (26/38, 68%) and half of the included articles (19/38)
did not report a justification for the sample sizes used in their studies.
Pooled estimates of the supply of antibiotics without prescription
The overall pooled estimate of non-prescription supply of antibiotics was 62% (95% CI 53 –
72) (Figure 2). This global estimate was comparable to the estimate for Asia (65%, 95% CI 54
– 76), the most studied region. The pooled estimate for Southern and Eastern Europe (53%,
95% CI 33 – 72) was comparable to that of Africa (57% 95% CI 16 - 99). The pooled estimate
for Africa, was lower than those for Asia (65%, 95% CI 54 – 76) and South America (78% 95%
CI 72 - 84). This was due to the low prevalence in the Zimbabwean study (Figure 2). Sensitivity
analysis conducted by excluding the Zimbabwean study yielded a pooled estimate of 74%
(95% CI 63 – 85) for Africa. However, the overall proportion (64%, 95% CI 55 – 73) of nonprescription supply of antibiotics in community pharmacies was similar to the estimate
obtained before the sensitivity analysis. Generally, non-prescription supply of antibiotics was
more frequent in Indonesia (91%, 95% CI 86 – 94), Syria (87%, 95% CI 82 – 91), Saudi Arabia
(85% 95% CI 72 – 99) and Ethiopia (85% 95% CI 75 – 92) (Figure 3).
Seven studies presented data on the proportion of non-prescription supply of antibiotics
following a specific product request by patients. The figures ranged from 16% (95% CI 10 –
22) in Spain

20

to 98% (95% CI 94 – 102) in Saudi Arabia

. The pooled estimate was 78%
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(95% CI 59 - 97). Similarly, the proportion of non-prescription supply of antibiotics based on
pharmacy staff recommendation following the presentation of clinical symptoms to them
ranged from 8% (95% CI 4 -12) in Zimbabwe 22 to 94% (95% CI 92 – 98) in India 23. The pooled
estimate based on pharmacy staff recommendation was 58% (95% CI 48 – 68) (Figure 4).
Subgroup meta-analysis showed a significant difference between the pooled proportions of
studies conducted from 2000 -2005 and 2011-2017 with estimates of 80% (95%CI 76 – 85)
and 56% (95% CI 43 – 69), respectively (Table 2). Overall, substantial heterogeneity was
6

observed on the pooled estimate of non-prescription supply of antibiotics (X2 = 4239.0, p <
0.001, I2= 99.1%). Of the sources of variation investigated through meta-regression, only
number of community pharmacies, study period and three quality criteria (reliability of
measurement, statistical analysis methods and generalisability of results) had p values below
0.10. These covariates yielded a significant multivariate model (p = 0.0193) that explained
25.3% of between-study variation.
Pooled estimates by symptom category
The proportion of non-prescription supply of antibiotics among patients with symptoms of
upper respiratory tract infections (URTI) ranged from 19% (95% CI 15 – 22) in a study in
Bosnia and Herzegovina

24

to 99% (95% CI 97 -100) in Vietnam

. The pooled estimate for
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URTI was 67% (95% CI 55 – 79) (Table 3). Penicillins were the most commonly recommended
and supplied medicines to treat symptoms of URTI (Figure 5). Pooled analysis by individual
type of antibiotics supplied revealed that amoxicillin 53% (95% CI 34-71; I2=98.0, p<0.001),
amoxicillin-clavulanic acid (co-amoxiclav) 39% (95% CI 23-54; I2 =97.4, p<0.001) and
azithromycin 19% (95% CI 11-27; I2=96.2, p<0.001) were commonly supplied for URTI.
The pooled estimates of non-prescription supply of antibiotics to patients with symptoms of
urinary tract infections (UTI) and acute gastroenteritis were 68% (95% CI 42-93) and 63%
(95% CI 46-80), respectively. Fluoroquinolones (69%, 95% CI 50-88) including ciprofloxacin
and norfloxacin were commonly supplied for UTI while metronidazole (55%, 95% CI 29-81)
was the most commonly supplied non-prescription antibiotic for acute gastroenteritis.
Two studies investigated non-prescription supply of antibiotics in patients with persistent
pulmonary tuberculosis. The proportions of non-prescription supply of antibiotics in these
studies were 27% (95% CI 25-30) and 24% (95% CI 18-31) in India and Cambodia,
respectively.
Nature of consultation and advice given
The proportion of patients that were referred to a medical prescriber without supplying an
antibiotic ranged from 3% (95% CI 1 - 6) in a study in Indonesia 26 to 38% (95% CI 35 - 40) in
a study in India.15 The pooled estimate for referral was 21% (95% CI 14 - 28).
Very few consultations that resulted in non-prescription supply of antibiotics enquired about
the patients’ drug history (12%, 95% CI 4-19) and allergies (32%, 95%CI 11-53) (Table 4).
The pooled proportion of the number of consultations with pharmacy staff that resulted in the
provision of information regarding the dose and duration of treatment with the supplied
antibiotics were 73% (95% CI 52-92) and 49% (95% CI 28-70), respectively. Four studies
reported on the proportion of women of childbearing age presenting with symptoms of UTI that
7

were asked about their pregnancy status prior to antibiotics being supplied. The proportion
ranged from 0% in a Spanish study 10 to 23% in a Saudi Arabian study.27
Discussion
This is the first study to provide pooled estimates of the extent of the supply of antibiotics
without prescription. Despite regional variations, supplying antibiotics without prescription
remains high globally. About three in four (78%) antibiotic requests and three in five (60%)
consultations (in relation to symptoms of infectious diseases) in community pharmacies
resulted in the supply of antibiotics without prescription. The majority of these antibiotics were
supplied for the treatment of disease conditions that were largely acute and self-limiting
including upper respiratory tract infections and gastroenteritis.
Many of the antibiotics supplied without a prescription were broad-spectrum antibiotics
including amoxicillin, amoxicillin-clavulanic acid, azithromycin and several fluoroquinolones.
The use of broad-spectrum antibiotics increases the risk of the development of resistant
infection including methicillin-resistant Staphylococcus aureus (MRSA). Broad-spectrum
antibiotics were commonly recommended even in conditions where there are equally effective
narrow spectrum antibiotics which can be used as first line therapies. For instance,
fluoroquinolones were commonly recommended and supplied for uncomplicated urinary tract
infections rather than the first-line narrow spectrum antibiotics such as trimethoprim and
nitrofurantoin. Such use of fluoroquinolones can promote the development of resistant UTIs.
A recent systematic review and meta-analysis estimating the global prevalence of antibiotic
resistance in paediatric urinary tract infections caused by E.coli reported a pooled prevalence
of 53.3% and 79.8% against ampicillin, and 2.1% and 26.8% against ciprofloxacin in OECD
countries and countries outside OECD respectively.28 Over the counter sale of antibiotics in
developing countries (outside OECD) was one of the reasons given by the authors to explain
the higher prevalence of resistance.28
Furthermore, the majority of the commonly supplied non-prescription antibiotics identified in
our review including amoxicillin, azithromycin and the fluoroquinolones have been classified
by the World Health Organisation as critically important antibiotics.29 This is because of their
unique place in the treatment of infectious diseases including being the sole or one of the
limited therapies for serious infections. For instance, macrolides remain part of a limited
treatment option for Campylobacter infections especially in children, in whom fluoroquinolones
are contraindicated.29 Therefore, the emergence of resistance to these antibiotics could have
a significant impact on population health given the high and increasing incidence of
campylobacter infections in children especially Campylobacter jejuni.30
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Results of this study also highlight some concerns around the safe supply and use of
antibiotics. Even though the safety of fluoroquinolones in pregnancy have not been fully
established, they were commonly supplied for UTIs to simulated patients who were of childbearing age without any check on their pregnancy status. In addition, only about one in three
patients were asked if they have any known drug allergy during consultations. While antibiotics
are largely perceived to be generally safe, serious adverse reactions including anaphylaxis
have been associated with many of them.31 Therefore, we recommend that all antibiotics
dispensing should have questions about allergy and pregnancy status in cases of women of
childbearing age to enhance their safe use.
Strict implementation of restrictions on over-the-counter sales of antibiotics has been shown
to be effective in reducing non-prescription antibiotic consumption in Brazil, Chile and South
Korea and Mexico.32-34 Given that many countries have laws prohibiting over-the-counter
sales of antibiotics, there is a need to ensure that these laws are strictly enforced. However, it
is important to understand that over-the-counter sale of some antibiotics may be supported in
certain contexts. For example, in the UK, pharmacists legally supplied using a patient group
direction, azithromycin to patients with positive chlamydia test results.35 Legislative changes
in some countries including Canada and New Zealand have given designated pharmacists the
authority to prescribe and dispense antibiotics for some conditions. For instance, in New
Zealand, pharmacists can prescribe and dispense trimethoprim for short-term treatment of an
uncomplicated UTI.35
Timely access and appropriate use of antibiotics have been associated with positive patient
outcomes in several serious bacterial infections including pneumonia.36 A significant
proportion of deaths caused by infections in many developing countries can be averted with
early diagnosis and treatment. However, in many of these countries, access to healthcare
facilities and prescribers are limited. Community pharmacies are often the first point of contact
for the public.35, 37

Therefore, community pharmacists trained in antibiotic stewardship in

these settings could play a significant role in ensuring prompt access to and rational use of
antibiotics. They could deliver treatment for certain bacterial infections using standard
treatment protocols, counsel patients on appropriate use of antibiotics, and prevent
unnecessary use of antibiotics for non-bacterial infections through appropriate treatment of
symptoms and counselling of patients to ensure they have a good understanding of their
illness.35 Hence, promoting rational use of antibiotics rather than just restricting the supply of
antibiotics without a prescription may be a more appropriate focus for any relevant policy in
these settings.

9

Finally, our study was limited by a lack of data from many countries. In addition, in countries
where data were available, we included many small local/regional studies which may not
necessarily reflect the extent of non-prescription supply of antibiotics across the whole nation.
Geographical variations (urban vs rural) within the same country in terms of non-prescription
supply of antibiotics cannot be ruled out. Therefore, our findings may have over or
underrepresented the actual extent of non-prescription supply of antibiotics. Our findings could
not take into account the impact of any national/regional policies targeted at reducing the
supply of antibiotics without prescription, which was implemented after the publication of the
included papers and has resulted in the reduction of non-prescription supply of antibiotics. We
only looked at the supply of antibiotics without prescription but not antifungals or antivirals,
which will be the focus of future research. Also, our aim was to estimate the global frequency
of supplying antibiotics without a prescription but not to assess the association between nonprescription supply of antibiotics and development of antibiotic resistance, an important area
for future research.
Conclusion
This review provides the most robust and up-to-date global estimate of the proportion of overthe-counter consultations and antibiotic requests that resulted in the dispensing of antibiotics
without a prescription. Despite the limitation of our review, the findings suggest that antibiotics
are frequently supplied without prescription in many countries even where this supply remains
illegal. This overuse of antibiotics could facilitate the development and spread of antibiotic
resistance. Our findings underscore the need for countries to enforce laws that limit the supply
of antibiotics without prescription in community pharmacies.
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Box 1: Search strategy
#

Searches

1

(antibiotic* or antimicrobial* or antibacterial*).af.

2

(Non-prescri* or Sale* or Supply* or over the counter or Dispens* or Selfmedication).af.

3

(community pharmac* or Pharmacy or pharmacies or Pharmacy shop* or Retail
pharmac* or Shop* or Drug store* or Drug shop*).af.

4

1 and 2 and 3

5

limit 4 to year="2000 -Current"

15

Tables and figures

3289 records identified through database

13 additional records identified through

searching (Medline 795, EMBASE 2328,

other sources

CINAHL 166)

2619 records after duplicates removed

2619 records screened

2545 records excluded after
reading titles and abstracts

74 full-text articles assessed for
eligibility

36 full-text articles excluded
Opinion-based survey (n= 14)
Duplicate reports (n= 2)
Reviews and letters (n= 7)
Conference abstract (n=2)
Qualitative studies (n=6)
No relevant data (n=5)

38 studies included in
quantitative synthesis (metaanalysis)

Figure 1: Flow diagram of article selection process
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Table 1 Characteristics of included studies
Authors

Study
location

Study design

Methods

Number of
community
pharmacies
involved

Number of
interactions
or
consultations

Risk of bias
classification

371

Proportion of
dispensing of
nonprescribed
antibiotics
(%)
57.4

Hussain et al.,38

Pakistan

Crosssectional

371

Puspitasari et
al.,26

Indonesia

Crosssectional

Almaaytah et
al.,39

Jordan

Crosssectional

Gastelurrutia et
al.,20

Spain

Crosssectional

Simulated patient visits
involving scenarios of
symptom of upper
respiratory tract infections
(URTI)
Simulated patient visits
involving specific product
request (ciprofloxacin
tablets and tetracycline
capsules)
Simulated patient visits
involving scenarios of
symptom of URTI,
gastroenteritis and urinary
tract infection (UTI) in
women of childbearing age
Simulated patient visits
involving specific product
requests and scenarios of
symptoms of UTI in
women of childbearing age

88

176

90.9

Low

202

202

74.3

Low

280

280

Moderate

131

131

Product
requests
(16.3) and
symptombased
scenarios
(18.7)
58

MarkovićPeković and
Grubisa,40

Bosnia and
Herzegovina

Crosssectional

Simulated patient visits
involving scenarios of
symptoms of URTI

17

Moderate

Moderate

Plachouras et
al., 41

Greece

Crosssectional

Quagliarello et
al., 25

Vietnam

Crosssectional

Shet et al., 42

India

Crosssectional

Volpato et al.,43

Brazil

Crosssectional

Llor & Cots,44

Spain

Crosssectional

Bin Abdulhak et
al., 27

Saudi
Arabia

Crosssectional

Al-Faham et al.,

Syria

Crosssectional

45

Simulated patient visits
involving specific product
requests
(amoxicillin/clavulanate
acid or ciprofloxacin)
Simulated patient visits
involving scenarios of
symptoms of URTI and
gastroenteritis in children
Simulated patient visits
involving scenarios of
symptoms of URTI in
adults and gastroenteritis
in children
Simulated patient visits
involving scenarios of
symptoms of URTI
Simulated patient visits
involving scenarios of
symptoms of URTI, acute
bronchitis and UTI in
women of childbearing age
Simulated patient visits
involving scenarios of
symptoms of URTI, acute
bronchitis, otitis media,
gastroenteritis and UTI in
women of childbearing age
aged women)
Simulated patient visits
involving scenarios of
symptoms of URTI

174

174

72.4

Moderate

75

150

86.7

Low

261

261

66.7

Low

107

107

74

Moderate

197

197

45.2

Low

327

327

77.6

Moderate

200

200

87

Moderate

18

Erku et al., 37

Ethiopia

Crosssectional

Simulated patient visits
involving specific product
requests (amoxicillin and
clavulanic acid capsule)
and scenarios of
symptoms of URTI

31

62

Product
requests
(93.5) and
symptombased
scenarios
(77.4)

Moderate

Diwan et al.,46

India

Crosssectional

164

164

40.2

Moderate

Hoxha et al., 47

Albania

cross-sectional

Simulated patient visits
involving scenarios of
symptoms of
gastroenteritis in children
Specific product request

323

323

80.2

Moderate

Chang et al., 48

China

cross-sectional

256

512

68.8

Low

Saengcharoen et
al., 49

Thailand

Crosssectional

32

128

87.5

Low

ContopoulosIoannidis et al.,
[50]
Vacca et al., 51

Greece

Crosssectional

98

98

77.6

Low

Columbia

cross-sectional

Simulated patient visits
involving scenarios of
symptoms of URTI in
adults and gastroenteritis
in children
Simulated patient visits
involving scenarios of
symptoms of URTI
Simulated patient visits
involving scenarios of
symptoms of URTI
Simulated patient visits
involving specific product
requests (amoxicillin,
azithromycin, ciprofloxacin
and trimethoprim /
sulfamethoxazole ) and
scenarios of symptoms of
URTI, gastroenteritis, otitis
media and UTI

200

239

80.3

Low

19

Saengcharoen &
Lerkiatbundit,14

Thailand

cross-sectional

Al-Mohamadi et
al., 21

Saudi
Arabia

Crosssectional

Guinovart et al.,

Spain

Crosssectional

Chalker et al., 52

Vietnam

cross-sectional

Kalungia et al.,53

Zambia

Crosssectional

Ibrahim et al.,54

Qatar

cross-sectional

Chuc et al., 55

Vietnam

Randomized
controlled trial

10

Simulated patient visits
involving scenarios of
symptoms of acute
gastroenteritis in children
Simulated patient visits
involving specific product
requests (co-amoxiclav or
cefaclor).

115

115

52.2

Low

60

60

97.6

Moderate

Simulated patient visits
involving scenarios of
symptoms of URTI, acute
bronchitis and UTI in
women of childbearing
age.
Simulated patient visits
involving scenarios of
symptoms of sexually
transmitted diseases
(STD)
structured intervieweradministered questionnaire
with simulated case
scenarios of symptoms of
URTI and UTI in
pregnancy
Simulated patient visits
involving scenarios of
symptoms of acute
gastroenteritis
Simulated patient visits
involving specific product
requests and scenarios of
symptoms of
uncomplicated URTI in a
child and STD in an adult
in an adult man

220

220

54.1

Moderate

60

295

81.5

Moderate

73

146

71.2

Moderate

30

60

43.9

Moderate

58

116

Product
requests
(94.8) and
symptombased
scenarios
(41.1)

Low

20

Salunkhe et al.,

India

cross-sectional

Simulated patient visits
involving scenarios of
symptoms of URTI or
diarrhoea

263

263

94.3

Moderate

Jaganathan et
al., 56

India

Crosssectional

120

120

72.5

Moderate

Amin et al., 57

Egypt

Crosssectional

Simulated patient visits
involving scenarios of
symptoms of acute
gastroenteritis and URTI
Simulated patient visits
involving scenarios of
symptoms of URTI

104

104

65.4

Low

Satyanarayana
et al., 15

India

Crosssectional

Simulated patient visits
involving scenarios of
symptoms of pulmonary
tuberculosis (TB)

622

1200

27

Low

Nyazema et al.,

Zimbabwe

Crosssectional

87

184

8.2

Moderate

Alabid et al., 58

Malaysia

Crosssectional

50

100

32

Moderate

Malik et al., 59

Pakistan

Crosssectional

Simulated patient visits
involving scenarios of
symptoms of STD and
gastroenteritis
Simulated patient visits
involving scenarios of
symptoms of URTI
Simulated patient visits
involving scenarios of
symptoms of malaria

238

238

28.6

Moderate

Bell et al., 60

Cambodia

Crosssectional

170

170

24.1

Low

Al-Ghamdi 61

Saudi
Arabia

Crosssectional

Interviewer-administered
questionnaire with
simulated case scenarios
of TB
Simulated patient visits
involving scenarios of
symptoms of UTI

88

88

81.8

Moderate

23

22

21

Homedes and
Ugalde, 62

Mexico

Crosssectional

Interviewer-administered
questionnaire with
simulated case scenarios
of URTI and gastroenteritis

25

49

71.4

Moderate

MarkovićPeković et al 24

Bosnia and
Herzegovina

Crosssectional

Simulated patient visits
involving scenarios of
symptoms of URTI

383

383

18.5

Low

Okuyan et al 63

Turkey

Crosssectional

Simulated patient visits
involving scenarios of
symptoms of URTI

70

70

45.7

Moderate
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Figure 2: Meta-analysis for the overall pooled proportion of non-prescription supply
of antibiotics
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Figure 3: Country level estimates of non-prescription supply of antibiotics
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Figure 4: Meta-analysis for the proportion of non-prescription supply of antibiotics
based on pharmacy staff recommendation
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Table 2: Subgroup meta-analysis of the proportion of non-prescription supply of
antibiotics
Subgroup

Estimate % (95%CI)

No. studies

Heterogeneity

Asia

65 (54 – 76)

23

I2 = 99.1%, p < 0.001

Africa

57 (16 – 99)

4

I2 = 99.3%, p < 0.001

Europe

53 (33 – 73)

8

I2 = 98.7%, p < 0.001

South America

78 (72 – 84)

2

I2 = 38.0%, p = 0.204

North America

71 (59 – 84)

1

ND

2011 - 2017

56 (43 – 69)

7

I2 = 99.1%, p < 0.001

2006 - 2010

62 (43 – 81)

12

I2 = 99.4%, p < 0.001

2000 - 2005

80 (76 – 85)

19

I2 = 71.8%, p = 0.002

≥ 100

58 (46 – 70)

23

I2 = 99.2%, p < 0.001

< 100

69 (52 – 85)

15

I2 = 99.0%, p < 0.001

Direct product request

85 (75 – 94)

4

I2 = 93.9%, p < 0.001

Symptom-based

59 (49 – 70)

30

I2 = 99.1%, p < 0.001

Mixed*

63 (26 – 99)

4

I2 = 99.3%, p < 0.001

Pharmacist only

59 (32 – 87)

5

I2 = 98.2%, p < 0.001

Mixed**

58 (42 – 74)

12

I2 = 99.0%, p < 0.001

Unspecified

65 (52 - 78)

21

I2 = 99.3%, p < 0.001

Yes

63 (53 - 73)

35

I2 = 99.1%, p < 0.001

No

55 (21 – 90)

3

I2 = 98.1%, p < 0.001

Region

Study period

Number of community
pharmacies included

Type of scenario

Category of pharmacy
staff

Concealment in
methodology

*studies that employed both direct product request and symptom-based scenario. **studies that included a
variety of pharmacy staff, ND – not determined
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Table 3: Pooled estimates on the proportion of antibiotics supplied without a
prescription by disease category
Symptom category

Estimate % (95% CI)

No. studies

Heterogeneity

URTI

67 (55–79)

23

I2 = 98.7%, p < 0.001

Bronchitis

42 (34-49)

2

I2 = 98.5%, p < 0.001

Otitis media

57 (47-68)

2

I2 = 57.0%, p = 0.127

Gastroenteritis

63 (46-80)

12

I2 = 98.6%, p < 0.001

UTI

68 (42-93)

6

I2 = 97.8%, p < 0.001

STD

47 (44-51)

2

I2 = 99.8%, p < 0.001

Pulmonary TB

27 (24-29)

2

I2 = 0.0%, p = 0.410

Malaria

29 (23-34)

1

ND

ND – not determined

100
90

% NP antibiotics supplied

80
70

Tetracyclines

60

Nitroimidazoles
Macrolides

50

Penicillins
Cephalosporins

40

Fluoroquinolones

30

Suphonamides

20
10
0

URTI

Gastroenteritis

UTI

Figure 5: Classes of antibiotics supplied without prescription for Gastroenteritis, URTI
and UTI
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Table 4: Nature of counselling provided during consultation
Nature of counselling
Asked patients about

Estimate % (95% CI)

No. studies

Heterogeneity

32 (11-53)

10

I2 = 99.4%, p < 0.001

12 (4-19)

6

I2 = 96.1%, p < 0.001

8 (1-18)

4

I2 = 82.5%, p = 0.003

73 (52-92)

11

I2 = 99.2%, p < 0.001

49 (28-70)

12

I2 = 99.2%, p < 0.001

21 (14-28)

16

I2 = 97.8%, p < 0.001

allergy
Asked patients about
any medicines they are
taking
Asked female patients
of child-bearing age
about pregnancy status
Explained the dose of
antibiotics
Explained how long to
take the antibiotics
Referred patients to a
physician
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